Comparison of serum antibody titers to Helicobacter pylori lipopolysaccharides, CagA, VacA and partially purified cellular extracts in a Japanese population

FEMS Microbiology Letters

Volumn 185, Issue 2, 2000, Pages 193-198

  Yokota, Shin Ichi ^a   Amano, Ken Ichi ^a   Fujii, Nobuhiro ^b   Yokochi, Takashi ^c  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

ELISA; Helicobacter pylori; Human serum; IgG; Lipopolysaccharide

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL POLYSACCHARIDE; BACTERIAL TOXIN; EPITOPE; IMMUNOGLOBULIN G;

ANTIBODY TITER; ANTIGENICITY; ARTICLE; DIGESTIVE SYSTEM ULCER; ENZYME LINKED IMMUNOSORBENT ASSAY; HELICOBACTER PYLORI; JAPAN; NONHUMAN; PRIORITY JOURNAL; STOMACH CANCER;

ADULT; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOGLOBULIN G; JAPAN; LIPOPOLYSACCHARIDES; RECOMBINANT PROTEINS;

HELICOBACTER PYLORI;

EID: 0034655978     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(00)00102-6     Document Type: Article

References (16)

1. Cover T.L., Blaser M.J. Helicobacter pylori infection, a paradigm for chronic mucosal inflammation: pathogenesis and implications for eradication and prevention. Adv. Intern. Med. 41:1996;85-117.
2. Parsonnet J. Helicobacter pylori: the size of the problem. Gut. 43:(Suppl. 1):1998;S6-S9.
3. Taylor D.N., Blaser M.J. The epidemiology of Helicobacter pylori infection. Epidemiol. Rev. 13:1991;42-59.
4. Asaka M., Kimura T., Kudo M., Takeda H., Mitani S., Miyazaki T., Miki K., Graham D.Y. Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology. 102:1992;760-766.
5. Covacci A., Telford J.L., Del Giudice G., Parsonnet J., Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 284:1999;1328-1333.
6. Yokota S., Amano K., Hayashi S., Fujii N. Low antigenicity of the polysaccharide region of Helicobacter pylori lipopolysaccharides derived from tumors of patients with gastric cancer. Infect. Immun. 65:1997;3509-3512.
7. Amano K., Yokota S., Ishioka T., Hayashi S., Kubota T., Fujii N. Utilization of proteinase K-treated cells as lipopolysaccharide antigens for the serodiagnosis of Helicobacter pylori infections. Microbiol. Immunol. 42:1998;509-514.
8. Cedzynski M., Amano K., Chmiela M., Lawnik M., Czkwianianc E., Planeta-Malecka I., Rudnicka W., Kaca W. Serum IgG antibodies in children and adults reacting with Helicobacter pylori lipopolysaccharides. Arch. Immunol. Ther. Exp. 46:1998;79-83.
9. Pece S., Messa C., Caccavo D., Giuliani G., Greco B., Fumarola D., Berloco P., Di Leo A., Jirillo E., Moran A.P. Serum antibody response against Helicobacter pylori NCTC 11637 smooth- and rough-lipopolysaccharide phenotypes in patients with H. Pylori-related gastropathy. J. Endotoxin Res. 4:1997;383-390.
10. Yokota S., Amano K., Shibata Y., Nakajima M., Suzuki M., Hayashi S., Fujii N., Yokochi T. Two distinct antigenic types of the polysaccharide chains of Helicobacter pylori lipopolysaccharides characterized by reactivity with sera from humans with natural infection. Infect. Immun. 68:2000;151-159.
11. Appelmelk B.J., Simoons-Smit I., Negrini R., Moran A.P., Aspinall G.O., Forte J.G., de Vries T., Quan H., Verboom T., Maaskant J.J., Ghiara P., Kuipers E.J., Bloemena E., Tadema T.M., Townsend R.R., Tyagarajan K., Crothers J.M. Jr., Monterio M.A., Savio A., de Graaff J. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 64:1996;2031-2040.
12. Wang G., Rasko D.A., Sherburne R., Taylor D.E. Molecular genetic basis for the variable expression of Lewis y antigen in Helicobacter pylori: analysis of the α (1,2) fucosyltransferase gene. Mol. Microbiol. 31:1999;1265-1274.
13. Appelmelk B.J., Martin S.L., Monteiro M.A., Clayton C.A., McColm A.A., Zheng P., Verboom T., Maaskant J.J., van den Eijnden D.H., Hokke C.H., Perry M.B., Vandenbroucke-Grauls C.M.J.E., Kusters J.G. Phase variation in Helicobacter pylori lipopolysaccharide due to changes in the lengths of poly(C) tracts in α3-fucosyltransferase genes. Infect. Immun. 67:1999;5361-5366.
14. Amano K., Hayashi S., Kubota T., Fujii N., Yokota S. Reactivities of Lewis antigen monoclonal antibodies with the lipopolysaccharides of Helicobacter pylori strains isolated from patients with gastroduodenal diseases in Japan. Clin. Diagn. Lab. Immunol. 4:1997;540-544.
15. Granberg C., Mansikka A., Lehtonen O.P., Kujari H., Gronfors R., Nurmi H., Raiha I., Stahlberg M.R., Leino R. Diagnosis of Helicobacter pylori infection by using Pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies. J. Clin. Microbiol. 31:1993;1450-1453.
16. Aromaa A., Kosunen T.U., Knekt P., Maatela J., Teppo L., Heinonen O.P., Harkonen M., Hakama M.K. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am. J. Epidemiol. 144:1996;142-149.